External Source

Public Meeting: Reauthorization Of The Biosimilar User Fee Act

2025 56:32
Synopsis
On December 3, 2025, the Food and Drug Administration (

You Might Also Like

Public Meeting: Reauthorization of the Biosimilar User Fee Act 56:32
Public Meeting: Reauthorization Of The Biosimilar User Fee A...
2025
Navigating the World of Biosimilar User Fees- June 10, 2019 22:48
Navigating The World Of Biosimilar User Fees- June 10, 2019
2020
FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics 6:02:10
Fda User Fee Reauthorization: Ensuring Safe And Effective Dr...
2022
E&C Health Subcommittee on FDA User Fee Reauthorization 5:19
E&c Health Subcommittee On Fda User Fee Reauthorization
2022
FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics 6:02:51
Fda User Fee Reauthorization: Ensuring Safe And Effective Dr...
2022
Rep. Fred Upton Speaks on Passage of FDA Reform 1:03
Rep. Fred Upton Speaks On Passage Of Fda Reform
2012
Examining FDA’s Prescription Drug User Fee Program. 2:04:27
Examining Fda’s Prescription Drug User Fee Program.
2017
Examining FDA’s Generic Drug and Biosimilar User Fee Programs. 2:35:02
Examining Fda’s Generic Drug And Biosimilar User Fee Progr...
2017
Health Policy Roundup: Background on FDA User Fee Programs 1:26:23
Health Policy Roundup: Background On Fda User Fee Programs
2022
Examining FDA’s Prescription Drug User Fee Program 2:27
Examining Fda’s Prescription Drug User Fee Program
2017
PDUFA Reauthorization: National Health Council Presentation 12:01
Pdufa Reauthorization: National Health Council Presentation
2015
FDA Interchangeable Products Workshop: Landscape of Stakeholder Perspectives 33:48
Fda Interchangeable Products Workshop: Landscape Of Stakehol...
2025
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.